Construction Business Review Conferences
BIOSPAIN 2026 will take place from 29 September to 1 October at the Bilbao Exhibition Centre (BEC), bringing together the global biotechnology community under the claim “Bioinnovation that clicks.” Organized by AseBio in collaboration with the Provincial Council of Bizkaia, the Basque Government and the Basque Health Cluster, the event reinforces its role as Spain’s flagship biotech congress and one of Europe’s leading life sciences gatherings. For the first time in its history, BIOSPAIN becomes an annual event, reflecting the sector’s growing momentum and international demand. The 2025 edition in Barcelona welcomed more than 2,400 attendees from 35 countries, confirming BIOSPAIN as a premier platform for business development, investment and strategic networking.
The Bioproduction Congress is the annual event of the biopharmaceutical production sector where stakeholders from Europe gather together to showcase and exchange the latest innovations in bioprocessing. This dynamic event promotes exchanges on the future of biomanufacturing, addresses the current challenges and showcases the new breakthrough solutions. This event will bring together experts from companies (big pharmas, SME and Startups) and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.
Life science organisations are under mounting pressure to prove the value of patient engagement in hard numbers. Regulators demand transparency in reporting, executives expect clear ROI before committing resources, and patients want visible proof their voices are driving decisions, accelerating timelines, and improving outcomes. Yet despite years of progress, a unified, credible framework for measuring impact still doesn’t exist - leaving engagement efforts vulnerable to being dismissed as well-intentioned but non-strategic.
Welcome to the European mRNA Conference 2026, where global pharmaceutical and biotechnology leaders meet industry experts to explore innovations in mRNA therapeutics for vaccines, personalised medicine, and beyond. This event explores the role of mRNA technology in developing novel treatments, covering research and development, clinical trials, large-scale manufacturing, and commercialisation. It highlights advances in RNA modification, therapeutic delivery systems, and vaccine development, showcasing the latest progress in mRNA medicine and oligonucleotide therapeutics.
The Antibody Industrial Symposium is a prestigious international congress jointly organized by the scientific society LabEx MAbImprove and the dynamic biotherapy industrial organization MabDesign. This event covers the latest advances and associated challenges in the field of therapeutic antibodies and their derivatives, recombinant proteins and other biomedicines, from R&D and into clinical phases. This symposium isn’t just another conference; it’s a vibrant platform where researchers, industry leaders, medical professionals, and policymakers converge to explore the latest advancements in therapeutic antibodies and beyond. It features captivating keynote lectures, dynamic pitch talks unveiling innovative projects, and insightful industry presentations from leading pharmaceutical companies.
Join us for the 3rd edition of Innovations for Cell and Gene Therapies congress that will be held on May 27-28, 2026 at Campus Sanofi Gentilly, France. This international conference brings together leading scientists, clinicians, researchers, and industry experts to explore the latest developments and groundbreaking applications in the Cell and Gene Therapies field. Through a diverse program of scientific lectures and networking sessions, attendees will discuss the challenges and opportunities in advancing these therapies, from the research phase to clinical application.
UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies, and more. Serving as a global gateway, the event connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking, and the discovery of new clients and partners.
The Pharma Partnering Summit – World Congress 2026 is a flagship international gathering designed to unite senior executives, business development leaders, and innovators from across the pharmaceutical and biotechnology industries. Taking place in Basel, Switzerland, a global hub for life sciences, the summit provides a dynamic platform for networking, collaboration, and strategic deal-making. The event focuses on business development and licensing (BD&L), R&D collaborations, alliances, M&A transactions, and investment opportunities. Attendees will gain insights into emerging therapeutic areas, innovative technologies, and evolving global partnering landscapes.
Swiss Biotech Day is a leading biotech conference in Basel, Switzerland on May 4-5, 2026, uniting 3,000+ life-science professionals from around the world to network, partner, showcase innovation and explore R&D, AI, financing and global collaborations.
Join us in Barcelona. The annual inflection point where we practice what we preach. 2026 brings you a reimagined experience, with the entire event rebuilt in 1 room that includes all 1,200 attendees, 4 cross-functional streams, interactive workshops and experiences. You must underpin your customer engagement strategy with reimagined data and infrastructure. You must reprioritise your launch plans to deliver value across patient priorities. Four separate pillars that become one reinforced foundation.
